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The Rh system if of great clinical interest because its antibo-
dies are involved in erythrocyte immune-mediated destruction; 
i.e., hemolytic transfusion reaction and hemolytic disease of the 
newborn (HDN)1. The first reports about its importance began 
around the year 1600, as a possible cause of severe jaundice 
and newborn death referred to as “erythroblastosis fetalis”2.  A 
French woman gave birth to twins: one was hydropic and the 
other was jaundiced, later dying of kernicterus. 
This wide variety of newborn signs and symptoms which 
ranges from light jaundice to fatal edema was not really 
associated with one single agent. The first correlation of an 
anti-erythrocyte antibody involved against the Rh antigen was 
reported by Levine et al. in 1939 through the investigation of 
a hemolytic transfusion reaction in a post-partum woman due 
to the transfusion of ABO red blood cells compatible with her 
husband, after giving birth to a stillborn3. This woman’s serum 
agglutinated her husband’s red blood cells, and that of about 
80% of compatible ABO donors. It was demonstrated that this 
new antibody was independent of the ABO, MN and P systems, 
suggesting the woman had probably been immunized by a fetal 
antigen from her father. 
In the following year, Landsteiner et al.4 described an 
antibody obtained through the immunization of guinea pigs and 
red blood cells of rhesus macaque. This serum agglutinated 
approximately 85% of tested human red blood cells and the 
corresponding determinant was called Rh factor. The study 
with 60 families showed that the positive Rh was inherited 
with dominant character. 
Also in 1940, Wiener et al.5 observed the same specificity 
in the serum of people who lacked the same determinant and 
who had received compatible ABO transfusions in the past. 
The following year, Levine et al.6 found similar antibodies in 
the serum of several post-partum women and these presented 
similar reactions to the anti-Rhesus animal serum. 
Later, in 1942, Fisk et al.7 showed the difference between 
the human and animal anti-Rh, and concluded that it was 
not the same antibody. The Rh nomenclature, however, was 
maintained. 
Only after 1963 Levine et al.8 proposed that the hetero-
antibody of rabbits should be named anti-LW (a tribute to 
Landsteiner and Wiener) and the human should be named 
anti-D. The Rh name resulted from the LW antigen. It was 
only in the mid-1940s that four additional antigens (C, c, E, 
e) were recognized as belonging to the Rh system. Race et 
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al.9, having four Rh antiserums of different specificities already 
defined seven alleles, whereas Wiener10, with three antiserums, 
determined six. 
Since his discovery, it was suspected that these antigens 
were transmitted in a block; one single gene encoded agglu-
tinogenic numbers, or three closely attached genes encoded 
several products. Currently, over 49 antigens have been iden-
tified through antibodies produced after blood transfusion or 
pregnancy. The main antigen, from a clinical point of view, is 
RhD, followed by Rhc. 
Antigen D is the most immunogenic of the Rh system, 20 
times more powerful than c. Approximately 80% of Rh negative 
individuals who receive Rh positive blood will produce anti-D 
antibodies after the first contact11 and only 7% to 8% of Rh 
negative individuals will remain non-responsive12.
Antibodies against RhD are the main cause of hemolytic 
disease of the newborn (HDN)13. The determination of Rh 
blood time is important, and should be carried out early in the 
pregnancy, because HDN presents with significant perinatal 
morbidity and mortality. RhD negative pregnant women with 
Rh positive fetuses could present sensitivization during labor, 
which answers for 14% of alloimmunization cases14. 
Even after the introduction of anti-D immunoglobin, in the 
late 1960s, and the combination of pre- and post-partum immu-
noprophylaxis in the late 1990s, the incidence of alloimmuni-
zation to antigen D ranges from 0.8% to 1.5% in RhD negative 
pregnant women, caused by fetal-maternal hemorrhage15. 
In Brazil, Rh alloimmunization is still the main cause of HDN 
and anti-D is still the main cause of the indication of photo-
therapy or exchange transfusion in newborns. The prophylaxis 
with immunoglobulin anti-D, when administered with the 
right dosage and in early stage, could prevent sensitivization 
to antigen D16-17. 
Therefore, detailed knowledge of the Rh system is of 
great importance, particularly in Obstetrics and Transfusion 
Medicine.
rh complex structure in red blood cells
The Rh blood group (ISBT 004) is the most complex, 
polymorphic and immunogenic blood group system known in 
humans. After the ABO, it is the most important in Transfusion 
Medicine18.
Five main and important antigens -- D(RH1), C(RH2), E 
(RH3), c(RH4) and e(RH5) – can be distinguished and are 
responsible for most clinically significant antibodies. With 
over 49 different antigens characterized, it is the largest of all 
blood systems. 
The Rh positive and Rh negative refer to the presence or 
absence of antigen D, but bith express antigens C\c and E\e. C 
is antithetical to c whereas antigen E is antithetical to e. Each 
chromosome contains the C or c and E or e genes18. 
The antigens are located in two proteins expressed in the 
membrane of erythrocytes and their immediate precursors: rhD 
(CD240D) and rhCE (CD240CE), which respectively carry 
antigens D(rh1) and C, c, E, e (rh2-rh5) in various combi-
nations (ce, cE, Ce and CE). Both proteins, RHD and RHCE, are 
hydrophobic and non-glycolized, each with a molecular weight 
of 30 to 32 KD, made up of 417 aminoacids distributed in six 
extracellular segments (responsible for the immune response), 
12 transmembranous and seven intracellular. The N-terminal 
and C-terminal portions are intracellular19. 
The RhD and RhCE proteins present with 92% homology 
and differentiate in 35/36 aminoacids (8.4% divergence), 
suggesting that the corresponding genes are the result of the 
duplication of a common ancestral gene19-20. This concept is 
based on the identification of Rh-like genes in non-human 
primates. The differences between RHD and RHCE occur in 
the extracellular region, in which loops (extracellular portions) 
2, 3, 4 and 6 are restricted (Figure 1). 
In the second loop, allele c differentiates proteins RhD and 
RhCE. Proteins C/c and E/e are produced by a mechanism of 
alternative pre-processing messenger RNA splicing and poly-
morphisms ser103-pro and pro226-ala and are responsible for 
the specificity of C/c and E/e, respectively21.
On the erythrocyte membrane, the Rh protein, along with 
the glycoprotein associated with Rh (rhAG/rH50), encoded 
by another gene located on chromosome 6p12-p21, form the 
so called “Rh complex”22. The Rh complex is firmly attached to 
the cytoskeleton of the erythrocyte membrane. Other additional 
proteins, such as LW, glycoprotein Duffy, band 3 and integrin-
associated protein (CD47) are linked to the Rh complex, but 
are not necessary to its expression (Figure 2). 
The expression of Rh on red blood cell surface depends on 
the functional RhAG protein. When there is absence of RH50 
protein, antigens D,E,C,e,c are not expressed, and the pheno-
type is referred to as Rhnull. Because they present homology with 
other proteins, proteins Rh and RhAG appear to be involved 
in the ammonia transportation. Additionally, it is supposed 
that they are also involved in the transportation of O2 and CO2 
gases. Changes in the shape of red blood cells, especially in 
individuals with Rhnull phenotype, indicate a strong interaction 
between the Rh complex and the cytoskeleton of the erythrocyte 
membrane22. 
Molecular basis of the rh system
The RHD gene was discovered in 1992, two years after the 
RHCE. Currently, although over 170 RHD alleles have been 
described, this gene has not yet been fully characterized. Many 
mammals present only one Rh gene corresponding to the RHCE 
gene in humans. 
Experiments conducted with the Southern Blot technique 
using a cDNA Rh probe have shown that only three species carry 
more than one Rh gene: chimpanzees, gorillas and humans23. 
The two genes of the Rh system (RHD and RHCE) are located 
on the short arm of chromosome 1, locus 34-36 (Figure 3). 
These are highly homologue genes (93.8%), each contai-
ning 10 exons, with a total sequence of approximately 60,000 
pb.
 The greatest difference is on intron 4, in which RHD 
contains a deletion of 600 pb in relation to RHCE. They are 
in opposite orientation by terminals 3´ and separated by a 
sequence of 30,000pb19-20. 
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The SMP1 gene (Small Membrane Protein 1) is interposed 
between RHD and RHCE. SMP1 is functionally related to Rh in 
terms of its expression on the erythrocyte membrane. RHD is 
flanked by two DNA segments with the size of 9000 pb, homo-
logy of 98.6% and identical orientation, called Rhesus boxes24. 
rHD negativity
D negative red blood cells do not entirely express the RhD 
protein on the erythrocyte surface. There are basically three 
molecular mechanisms of RHD negativity: total deletion of 
RHD gene, RHD pseudogene and hybrid gene, which vary in 
frequency according to the race in question19. In Caucasians, 
found in 15% to 17% of the population, the most common 
mechanism is the complete deletion of the RHD gene. The RhD 
negative phenotype is most commonly caused by homozygosis 
of a haplotype in which the RHD gene has been deleted. This 
deletion occurs in Rhesus boxes in a region that is identical to 
1463 pb, probably caused by defective chromosome alignment 
during meiosis, resulting in an unequal crossing-over between 
Rhesus boxes. The result is characterized by the presence of a 
hybrid Rhesus Box24. Few cases may result from genie rearran-
gements or point mutations leading to stop codon.
The RHD gene could also not be expressed due to premature 
stop codon, nucleotide insertions, point mutations, or hybrid 
RHD/CE. Fourteen different D- alleles are described with a 
frequency of 1/1500 in the Caucasian population19. 
The deletion of the RHD gene is observed in only 18% of the 
Afrodescendant population and in 60% of Asians, considering 
that, among the latter, the RHD gene is found in less than 1% 
of the population. 
The most common variant in D negative Asians is the pheno-
type Del RHD (K409K), i.e., 10% to 30% have the RHD gene 
intact18. Various mechanisms contribute to the vast number of 
non-functioning Rh alleles. 
In Afrodescendants with RhD negative phenotype, the 
most common mechanism is the presence of the pseudogene 
RHD(RHDø), associated with the ce allele in the RHCE. The 
RHD pseudogene contains a duplicate sequence of 37 pb, 
compromising the the last 19 nucleotides of intron 3 and the 
first 18 nucleotides of exon 4, thus causing four missense 
mutations in exon 5 (609G>A, 654G>C, 667T>G, 674C>T) 
and one nonsense mutation in exon 6 (807T>G), which causes 
the creation of a stop codon signal(Y269X)25-29. 
In this way, a non-functional protein is produced and no 
polypeptide D reaches the erythrocyte surface. This generates 
non-functional Rh protein, representing approximately 70% of 
Afrodescendant with an inactive gene. Currently, RHDØ detec-
tion through the polymerase chain reaction (PCR) method is 
considered mandatory for any antigen D prediction19.
Regarding the Rh negative phenotype due to hybrid gene, 
the high similarity in opposite directions and the proximity to 
the same chromosome favor a cis gene conversion and the 
formation of a hairpin loop, in which the inner part of a gene 
is exchanged by corresponding parts of another gene. The 
results of this mutation are the hybrid alleles RHD-CE-D and 
RHCE-D-CE. 
The hybrid gene RHD-CE (4-7)D (Ces) contains both altered 
genes: a hybrid gene RHD-CE-D segregated as ces allele of 
the RHCE. The haplotype (C)ces has two different molecular 
bases30.
- Type 1, which consists of exons 1, 2 , terminal 5´ of exons 
8, 9 and 10 of the RHD gene, joined with terminal 3´ of exon 
3 starting on nucleotide 455, exons 4 to 7 of the RHCE gene. 
- Type 2, in which the hybrid gene has a fusion of exons 
1, 2, complete 3, 8, 9 and 10 of the RHD gene, joined with 
exons 4 to 7 of the RHCE gene. 
Both encode two nucleotides 733C>G (exon 5) and 
1006G>T (exon 7) carried by RHCE, generating two substitu-
tions, respectively: Leu245Val in the eighth transmembranous 
region and Gly336Cys in the eleventh. The haplotype (C)
ces encodes a partial C,c associated with a weak e and with 
antigen VS. 
This mechanism is the second most frequent Afrodescen-
dant RhD negative phenotype, associated with phenotype VS 
V- with a frequency of 0.03%. In Asians, however, the hybrid 
gene RHD-CE (2-9) is the most common in Rh negative donors, 
after the Del phenotype31-32. 
Weak D expression 
Normally, RhD positive red blood cells have an antigenic 
density ranging from 15000 to 33000 antigens per cell, depen-
ding on the haplotype. However, some phenotypes with density 
ranging from 70 to 5200 RhD antigens have been identified. 
These phenotypes are called weak D and are caused by the 
substitution of aminoacids in the transmembranous and intra-
cellular portions of the RhD protein due to a single missense 
mutation in the RHD gene. Weak D phenotype red blood cells 
express an intact antigen RhD, and occur in 0.2% to 1% of 
caucasians33. 
Currently, over 40 types of weak D have been identified 
on the molecular level, in among which the most frequent are 
weak D type 1 and 2 (70% and 18%, respectively). Due to the 
fact that the weak D phenotype carries the intact RhD antigen, 
the probability of forming anti-d alloantibody is very unlikely. 
However, the presence of anti-D in some weak D cases (type 
1, 4.2 and 15) has been reported34-35. 
The difference between weak D and partial D must not 
be drawn by the production of anti-D. To predict the risk of 
immunization in weak D individuals, the Rhesus index was 
proposed34. This index is based on the antigenic density of 
various monoclonal antibodies, depending on the quantity of 
antigenic sites and on the affinity of the antibody. Theoretically, 
the index could range from 1 (low risk, e.g., normal RhD) to 0 
(high risk, e.g., partial RhD with missing epitopes). Type 4.2 
and 15 weak D present the lowest Rhesus index (0.21), with 
the exception of type 7 (0.03). 
Partial D expression 
Antigen D is made up of numerous epitopes and partial 
D expression was originally defined by D individuals who 
presented with anti-D formation. Studies with monoclonal 
antibodies have defined over de 30 highly conformational 
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Figure 1 – schematics of the rh proteins on the erythrocyte 
membrane
Legend: Adapted from Wagner EF, Flegel WA. Review: the molecular basis of the Rh blood group 
phenotypes. Immunoematology 2004;20:23-35.
epitopes36, involving various extracellular loops. 
Partial D red blood cells are defined by the absence of one 
or more epitopes caused by the rearrangement of the RHD and 
Figure 2 – schematics of the rh complex on the erythrocyte 
membrane  
Legend: Adapted from Kim CLV, Colin Y, Cartron JP. Rh proteins: Key structural and functional 
components of the red cell membrane. Blood Reviews 2006;20:93-110.
Figure 3- structure of the rHD and rHCE genes and their 
respective polypeptides
Legend: Adapted from Martine GHM Tax. Rh variabiliteit vanuit multi-etnisch perspectief Con-
sequenties voor RH genotypering. © 2005, Rotterdam, The Netherlands. ISBN 90-9020176-9
RHCE genes. This genetic configuration enables microconver-
sion and single-direction exchanges of fragments of RHD and 
RHCE gene fragments or parts, leading to the formation of 
RHD-CE-D or RHCE-D-CE alleles, respectively37. These new 
Rh aberration alleles not only produce hybrid proteins, RhD 
regions joined with RhCE leading to the loss of D epitopes, but 
also generate new antigens. 
Few partial D phenotypes result from exchanges of one 
single aminoacid. However, in contrast with weak D, poly-
morphism occurs in the extracellular segments of the RhD 
protein. Partial D individuals may frequently produce anti-D 
against those absent epitopes when exposed to the complete 
RhD protein. 
This clarification of the molecular basis of the Rh system 
has enabled the development of serum-based and molecular 
techniques to determine these variants among the various 
populations. In the field of Obstetrics, it enables unveiling the 
Rh negative phenotype in pregnant women, thus aiding in the 
understanding of the correlation between phenotype, genotype 
and Rh alloimmunization. Although there is high concordance 
between the phenotyping and genotyping of the Caucasian 
population, false-positive results are observed in Afrodescen-
dant and Asians, which could frequently occur depending on 
the strategy used. 
Another advantage of the molecular study would be to avoid 
unnecessary anti-D immunoprophylaxis (3% to 5%)38 in RhD 
negative pregnant women with a specific type of weak D, as 
well as the identification of partial D pregnant women who 
present a high probability of alloimmunization and require Rh 
immunoprophylaxis. 
This reasoning can also be extended to Transfusion Medi-
cine, thus preventing many complications and reactions after 
transfusions.
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